Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 267 articles:
HTML format
Text format



Single Articles


    May 2017
  1. ROZEMEIJER R, Stein M, Frambach P, Voskuil M, et al
    Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27142.
    PubMed     Text format     Abstract available


  2. WITBERG G, Finkelstein A, Barbash I, Assali A, et al
    Prognostic significance of aortic valve gradient in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27124.
    PubMed     Text format     Abstract available


  3. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
    Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27105.
    PubMed     Text format     Abstract available


  4. LINKE A, Chandrasekhar J, Sartori S, Lefevre T, et al
    Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27154.
    PubMed     Text format     Abstract available


  5. HENGSTENBERG C, Chandrasekhar J, Sartori S, Lefevre T, et al
    Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 11. doi: 10.1002/ccd.27155.
    PubMed     Text format     Abstract available


  6. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27098.
    PubMed     Text format     Abstract available


  7. GREENBAUM AB, Condado JF, Eng M, Lerakis S, et al
    Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27054.
    PubMed     Text format     Abstract available


  8. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available


    April 2017
  9. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available


  10. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available


  11. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available


    March 2017
  12. DIN JN, Snow TM, Rao SV, Klinke WP, et al
    Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 31. doi: 10.1002/ccd.26992.
    PubMed     Text format     Abstract available


  13. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available


  14. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available


  15. AZZALINI L, Carlino M, Brilakis ES, Vo M, et al
    Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture".
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27025.
    PubMed     Text format     Abstract available


  16. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available


  17. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available


  18. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available


  19. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available


  20. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available


  21. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available


  22. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available


  23. GUERRERO M, Wang DD, Himbert D, Urena M, et al
    Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26975.
    PubMed     Text format     Abstract available


  24. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available


  25. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  26. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  27. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    


  28. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  29. LIAO YB, Zhao ZG, Wei X, Xu YN, et al
    Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  30. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  31. BELARDI JA, Albertal M
    Non-cardiac surgery after PCI: Watch out for complex lesions.
    Catheter Cardiovasc Interv. 2017;89:627-628.
    PubMed     Text format    


  32. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    


    February 2017
  33. ZAHR F, Cigarroa JE
    Revascularization after coronary artery bypass grafting; Another episode in a long saga.
    Catheter Cardiovasc Interv. 2017;89:349-350.
    PubMed     Text format    


  34. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available


  35. BUTERA G, Piazza L, Heles M
    PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
    Catheter Cardiovasc Interv. 2017;89:480-483.
    PubMed     Text format     Abstract available


  36. JAMES RODRIGUEZ R, Prasad A
    Transcatheter aortic valve replacement and renal function: A complex relationship.
    Catheter Cardiovasc Interv. 2017;89:460-461.
    PubMed     Text format    


  37. PELBERG J, Gray WA
    Good to great: TAVR tackles stroke risk.
    Catheter Cardiovasc Interv. 2017;89:478-479.
    PubMed     Text format    


  38. CONDADO JF, Block PC
    Gender inequalities in transcatheter aortic valve replacement: The jury is still out.
    Catheter Cardiovasc Interv. 2017;89:436-437.
    PubMed     Text format    


  39. YADAV PK, Gilchrist IC
    Significant leak after TAVR: A plug is an option.
    Catheter Cardiovasc Interv. 2017;89:468-469.
    PubMed     Text format    


  40. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available


  41. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available


  42. DEHARO P, Strange JW, Mozid A
    Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26905.
    PubMed     Text format     Abstract available


  43. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available


  44. PARSH J, Seth M, Green J, Sutton NR, et al
    Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26917.
    PubMed     Text format     Abstract available


  45. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
    A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
    PubMed     Text format     Abstract available


  46. COHOON KP, Mack MJ, Holmes DR
    Public reporting: A new threat to high-risk patients and medical innovation.
    Catheter Cardiovasc Interv. 2017;89:335-337.
    PubMed     Text format    


  47. BOLER AN, Hilliard AA, Gordon BM
    Functional assessment of anomalous right coronary artery using fractional flow reserve: An Innovative Modality to Guide Patient Management.
    Catheter Cardiovasc Interv. 2017;89:316-320.
    PubMed     Text format     Abstract available


  48. POTERUCHA JT, Taggart NW, Johnson JN, Cannon BC, et al
    Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Catheter Cardiovasc Interv. 2017;89:306-314.
    PubMed     Text format     Abstract available


  49. LIGON RA, Petit CJ
    Not that atretic: Use of an atretic femoral vein for transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2017;89:321-323.
    PubMed     Text format     Abstract available


  50. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available


  51. PAREKH D, Krajcer Z
    Atrial baffle stenting: A complex solution to an aging problem.
    Catheter Cardiovasc Interv. 2017;89:314-315.
    PubMed     Text format    


  52. HAGLER DJ
    The Lababidi Procedure: Is Neonatal Balloon Aortic Valvotomy Worth the Risk?
    Catheter Cardiovasc Interv. 2017;89:296-297.
    PubMed     Text format    


    January 2017
  53. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available


  54. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available


  55. MCCABE JM, Dean LS
    Pass the Rock: calcium, the achilles heel of transcatheter valve replacement.
    Catheter Cardiovasc Interv. 2017;89:142-143.
    PubMed     Text format     Abstract available


  56. CHATTERJEE A, Hillegass WB
    Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
    Catheter Cardiovasc Interv. 2017;89:11-12.
    PubMed     Text format     Abstract available


    December 2016
  57. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available



  58. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by transradialaccess site and systemic implementation of AngioX) sub-study.
    Catheter Cardiovasc Interv. 2016;88:1188.
    PubMed     Text format    


  59. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
    Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;88:1067-1074.
    PubMed     Text format     Abstract available


  60. KRAJCER Z, Parekh D
    Dynamic Sheaths, in the Nick of Time or Past Their Prime?
    Catheter Cardiovasc Interv. 2016;88:1153-1154.
    PubMed     Text format     Abstract available


  61. BROWN BJ, Abbott JD
    A helping hand: GuideLiner use to facilitate stent delivery.
    Catheter Cardiovasc Interv. 2016;88:1065-1066.
    PubMed     Text format     Abstract available


    November 2016
  62. MASSUMI M, Krajcer Z
    To BAV or not to BAV, that is a TAVR question.
    Catheter Cardiovasc Interv. 2016;88:986-987.
    PubMed     Text format    


  63. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    


  64. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    


  65. FAURIE B, Abdellaoui M, Wautot F, Staat P, et al
    Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.
    Catheter Cardiovasc Interv. 2016;88:988-993.
    PubMed     Text format     Abstract available


  66. RUPARELIA N, Mangieri A, Ancona M, Giannini F, et al
    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.
    Catheter Cardiovasc Interv. 2016;88:994-1001.
    PubMed     Text format     Abstract available


  67. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available


  68. PRASAD M, Geske JB, Sorajja P, Ommen SR, et al
    Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Catheter Cardiovasc Interv. 2016;88:962-970.
    PubMed     Text format     Abstract available


  69. KAWAMOTO H, Latib A, Ruparelia N, Boccuzzi GG, et al
    Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry.
    Catheter Cardiovasc Interv. 2016;88:881-889.
    PubMed     Text format     Abstract available


  70. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available


  71. ASHER E, Mansour J, Wheeler A, Kendrick D, et al
    Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26835.
    PubMed     Text format     Abstract available


  72. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available


  73. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
    Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
    PubMed     Text format     Abstract available


  74. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available


  75. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed     Text format    


  76. SARRAF M, Hillegass W
    Routine invasive evaluation in non ST elevation myocardial infarction (NSTEMI-ACS): Optimizing best.
    Catheter Cardiovasc Interv. 2016;88:775-776.
    PubMed     Text format    


  77. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Text format     Abstract available


  78. ELGENDY IY, Kumbhani DJ, Mahmoud AN, Wen X, et al
    Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;88:765-774.
    PubMed     Text format     Abstract available


  79. LINDSAY I, Aboulhosn J, Salem M, Levi D, et al
    Aortic root compression during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:814-821.
    PubMed     Text format     Abstract available


    October 2016
  80. KISCHE S, D'Ancona G, Agma HU, El-Achkar G, et al
    Trans-catheter aortic valve implantation with the direct flow medical prosthesis: Single center short-term clinical and echocardiographic outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26528.
    PubMed     Text format     Abstract available


  81. D'ANCONA G, Agma HU, Ince H, El-Achkar G, et al
    Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26517.
    PubMed     Text format     Abstract available


  82. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available


  83. SCHNEIDER AE, Delaney JW, Cabalka AK
    Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
    Catheter Cardiovasc Interv. 2016;88:600-604.
    PubMed     Text format     Abstract available


  84. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available


  85. ABRAHAM BP, Gilliam E, Kim DW, Wolf MJ, et al
    Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival.
    Catheter Cardiovasc Interv. 2016;88:592-599.
    PubMed     Text format     Abstract available


  86. ANGULO-LLANOS R, Sarnago-Cebada F, Rivera AR, Elizaga Corrales J, et al
    Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis.
    Catheter Cardiovasc Interv. 2016;88:626-634.
    PubMed     Text format     Abstract available


  87. YILDIRIM A, Goktekin O, Gorgulu S, Norgaz T, et al
    A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial.
    Catheter Cardiovasc Interv. 2016;88:618-624.
    PubMed     Text format     Abstract available


  88. TEBALDI M, Biscaglia S, Fineschi M, Manari A, et al
    Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study).
    Catheter Cardiovasc Interv. 2016;88:555-562.
    PubMed     Text format     Abstract available


  89. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available


  90. SAFIAN RD
    The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
    Catheter Cardiovasc Interv. 2016;88:506-507.
    PubMed     Text format    


  91. PAIXAO A, Cilingiroglu M
    Paravalvular Leaks: One Size (or Shape) Doesn't Always Fit All?
    Catheter Cardiovasc Interv. 2016;88:624-625.
    PubMed     Text format     Abstract available


  92. DAVIDSON LJ, Davidson CJ
    Stroke Prevention: Let's Prepare for Generation X TAVR.
    Catheter Cardiovasc Interv. 2016;88:653-655.
    PubMed     Text format     Abstract available


  93. FELDMAN T, Nietlispach F
    Surgical vs. Percutaneous Approaches to Paravalvular Leak: Is Closure Too Little Too Late, or Just Not Soon Enough.
    Catheter Cardiovasc Interv. 2016;88:634-635.
    PubMed     Text format    


    September 2016
  94. WANG H, Li Y, Cong H, Ding S, et al
    Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Catheter Cardiovasc Interv. 2016 Sep 28. doi: 10.1002/ccd.26804.
    PubMed     Text format     Abstract available


  95. VERMA S, Burkhoff D, O'Neill WW
    Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
    PubMed     Text format     Abstract available


  96. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available


  97. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available


  98. SULLIVAN PM, Rubio AE, Johnston TA, Jones TK, et al
    Long-term outcomes and re-interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single-center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26722.
    PubMed     Text format     Abstract available


  99. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available


  100. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available


  101. BROWN SC, Cools B, Gewillig M
    Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.
    Catheter Cardiovasc Interv. 2016;88:456-9.
    PubMed     Text format     Abstract available


  102. KORNOWSKI R
    The 3 S's of the Sapien balloon expandable valve.
    Catheter Cardiovasc Interv. 2016;88:476-8.
    PubMed     Text format     Abstract available


  103. SOTOMI Y, Serruys PW
    Promising, but still a matter of debate.
    Catheter Cardiovasc Interv. 2016;88:378-9.
    PubMed     Text format     Abstract available


  104. BELARDI JA, Albertal M
    To achieve, or not to achieve complete revascularization.
    Catheter Cardiovasc Interv. 2016;88:338-9.
    PubMed     Text format     Abstract available


  105. GOLDSTEIN JA
    Stenting precision: "Image small, miss small".
    Catheter Cardiovasc Interv. 2016;88:348-9.
    PubMed     Text format     Abstract available


    August 2016
  106. KORABATHINA R, Levine JC, Coppola JT
    Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
    PubMed     Text format     Abstract available


  107. AMINIAN A, Iglesias JF, Van Mieghem C, Zuffi A, et al
    First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26773.
    PubMed     Text format     Abstract available


  108. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
    Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
    PubMed     Text format     Abstract available


  109. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available


  110. PATEL AD, Ibrahim M, Swaminathan RV, Minhas IU, et al
    Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 13. doi: 10.1002/ccd.26664.
    PubMed     Text format     Abstract available


  111. MINGES KE, Herrin J, Fiorilli PN, Curtis JP, et al
    Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26701.
    PubMed     Text format     Abstract available


  112. MENEGUZ-MORENO RA, Ramos AI, Siqueira D, de Castro-Filho A, et al
    Prognostic value of renal function in patients with aortic stenosis treated with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26693.
    PubMed     Text format     Abstract available


  113. BRADLEY EA, Berman D, Daniels CJ
    First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
    Catheter Cardiovasc Interv. 2016;88:248-52.
    PubMed     Text format     Abstract available


  114. NOONAN P, Kudumula V, Anderson B, Ramchandani B, et al
    Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;88:225-32.
    PubMed     Text format     Abstract available


  115. JIVANJI SG, Derrick G, Khambadkone S
    Doubly committed subarterial ventricular septal defect: A risk factor for aortic distortion in patients considered for percutaneous pulmonary valve implantation?
    Catheter Cardiovasc Interv. 2016;88:244-7.
    PubMed     Text format     Abstract available


  116. SPITZER SG, Wilbring M, Alexiou K, Stumpf J, et al
    Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Catheter Cardiovasc Interv. 2016;88:E52-8.
    PubMed     Text format     Abstract available


    July 2016
  117. KATZ M, Carlos Bacelar Nunes Filho A, Caixeta A, Antonio Carvalho L, et al
    Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016 Jul 29. doi: 10.1002/ccd.26658.
    PubMed     Text format     Abstract available


  118. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
    Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
    PubMed     Text format     Abstract available


  119. GUERRERO M, Wang DD, O'Neill W
    Percutaneous alcohol septal ablation to acutely reduce left ventricular outflow tract obstruction induced by transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26649.
    PubMed     Text format     Abstract available


  120. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
    Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
    PubMed     Text format     Abstract available


  121. SAFIAN RD
    Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
    Catheter Cardiovasc Interv. 2016;88:84-5.
    PubMed     Text format     Abstract available


  122. DANEK BA, Brilakis ES
    How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016;88:15-7.
    PubMed     Text format     Abstract available


  123. BROWN SC, Proesmans M, Gewillig M
    Reversing left bronchus obstruction by compression of a pulmonary artery stent.
    Catheter Cardiovasc Interv. 2016;88:103-6.
    PubMed     Text format     Abstract available


    June 2016
  124. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
    Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
    PubMed     Text format     Abstract available


  125. COCKBURN J, Dooley M, Parker J, Hill A, et al
    Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26623.
    PubMed     Text format     Abstract available


  126. WERNER N, Zeymer U, Schneider S, Bauer T, et al
    Incidence and clinical impact of stroke complicating transcatheter aortic valve implantation: Results from the German TAVI registry.
    Catheter Cardiovasc Interv. 2016 Jun 3. doi: 10.1002/ccd.26612.
    PubMed     Text format     Abstract available


  127. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available


    May 2016
  128. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
    Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
    PubMed     Text format     Abstract available


  129. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
    Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
    PubMed     Text format     Abstract available


  130. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
    Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
    PubMed     Text format     Abstract available


  131. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available


  132. BANDALI A, Parry-Williams G, Kassam A, Palmer S, et al
    Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26564.
    PubMed     Text format     Abstract available


  133. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
    Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
    PubMed     Text format     Abstract available


  134. BOCKSCH W, Grossmann B, Geisler T, Steeg M, et al
    Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26562.
    PubMed     Text format     Abstract available


  135. CHANDRASEKHAR J, Baber U, Sartori S, Faggioni M, et al
    Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study.
    Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26606.
    PubMed     Text format     Abstract available


  136. GONSKA B, Seeger J, Rodewald C, Scharnbeck D, et al
    Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26565.
    PubMed     Text format     Abstract available


  137. LEVI DS, Sinha S, Salem MM, Aboulhosn JA, et al
    Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: Initial experience and development of a new delivery platform.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26398.
    PubMed     Text format     Abstract available


  138. CHEN J, Nawaz N, Fox Z, Komlo C, et al
    Echocardiographic determinants of LV functional improvement after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016;87:1164-72.
    PubMed     Text format     Abstract available


  139. BLANKENSHIP JC
    Passion: A day in the life of an interventionalist.
    Catheter Cardiovasc Interv. 2016;87:999-1000.
    PubMed     Text format    


  140. DE WOLF D, Dessy H, Haas N
    Use of a new low profile Occlutech PLD device for closure of Fontan fenestrations.
    Catheter Cardiovasc Interv. 2016;87:E243-7.
    PubMed     Text format     Abstract available


  141. PIHKALA JI, Jarvela M, Boldt T, Jokinen E, et al
    Fate of fenestration in children treated with fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E233-9.
    PubMed     Text format     Abstract available


  142. BUTERA G, Taha F
    Two problems and a single solution: Covered stent implantation to close an anterograde pulmonary flow and treat hypoplastic left pulmonary artery after Fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E240-2.
    PubMed     Text format     Abstract available


    April 2016
  143. O'NEILL BP, Wheatley G, Bashir R, Edmundowicz D, et al
    Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26530.
    PubMed     Text format     Abstract available


  144. ZAMAN S, Gooley R, Cheng V, McCormick L, et al
    Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Apr 23. doi: 10.1002/ccd.26371.
    PubMed     Text format     Abstract available


  145. HIRA RS, Dean LS
    STAR in CTO PCI: When is STAR not a star?
    Catheter Cardiovasc Interv. 2016;87:893-4.
    PubMed     Text format     Abstract available


  146. VALLURUPALLI S, Uretsky BF
    Deploying bioresorbable vascular scaffolds--tardus, altius, amplius!!
    Catheter Cardiovasc Interv. 2016;87:847-8.
    PubMed     Text format     Abstract available


  147. OESTREICH BA, Sommer P, Armstrong EJ
    Coronary artery embolism from infectious endocarditis treated with catheter thrombectomy using a GuideLiner catheter.
    Catheter Cardiovasc Interv. 2016;87:E197-201.
    PubMed     Text format     Abstract available


  148. INOHARA T, Hayashida K, Watanabe Y, Yamamoto M, et al
    Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.
    Catheter Cardiovasc Interv. 2016;87:963-70.
    PubMed     Text format     Abstract available


  149. FABRIS E, Caiazzo G, Kilic ID, Serdoz R, et al
    Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Catheter Cardiovasc Interv. 2016;87:839-46.
    PubMed     Text format     Abstract available


  150. TANAKA A, Ruparelia N, Kawamoto H, Sticchi A, et al
    Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Catheter Cardiovasc Interv. 2016;87:832-6.
    PubMed     Text format     Abstract available


  151. FUJITA B, Scholtz S, Ensminger S
    Valve-in-valve using an Edwards Sapien XT into a JenaValve in a patient with a low originating left coronary artery and a heavily calcified aorta.
    Catheter Cardiovasc Interv. 2016;87:989-92.
    PubMed     Text format     Abstract available


  152. SUAREZ DE LEZO J, Martin P, Mazuelos F, Novoa J, et al
    Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Catheter Cardiovasc Interv. 2016;87:E173-82.
    PubMed     Text format     Abstract available


  153. TOROK RD, Fleming GA, Hill KD
    Transcatheter pulmonary embolectomy after fontan.
    Catheter Cardiovasc Interv. 2016;87:939-44.
    PubMed     Text format     Abstract available


    March 2016
  154. LATIB A, Pedersen W, Maisano F, Lesser J, et al
    Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis.
    Catheter Cardiovasc Interv. 2016 Mar 6. doi: 10.1002/ccd.26462.
    PubMed     Text format     Abstract available


  155. SZERLIP M, Kim RJ, Adeniyi T, Thourani V, et al
    The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26347.
    PubMed     Text format     Abstract available


  156. KHAN AR, Khan S, Riaz H, Luni FK, et al
    Efficacy and safety of transcatheter aortic valve replacement in intermediate surgical risk patients: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26465.
    PubMed     Text format     Abstract available


  157. ROCKEFELLER T, Shahanavaz S, Zajarias A, Balzer D, et al
    Transcatheter implantation of SAPIEN 3 valve in native right ventricular outflow tract for severe pulmonary regurgitation following tetralogy of fallot repair.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26480.
    PubMed     Text format     Abstract available


  158. CONDADO JF, Block PC
    Is it really "paradoxical" or just the ventricle?
    Catheter Cardiovasc Interv. 2016;87:805-6.
    PubMed     Text format     Abstract available


  159. KARATASAKIS A, Brilakis ES
    Atherectomy for calcified coronary lesions: When and how?
    Catheter Cardiovasc Interv. 2016;87:701-2.
    PubMed     Text format     Abstract available


  160. CHANDRASEKHAR J, Mehran R
    Orbital atherectomy for severely calcified lesions: More dissections in women but similar 30-day outcomes to men.
    Catheter Cardiovasc Interv. 2016;87:678-9.
    PubMed     Text format     Abstract available


  161. BUTMAN SM
    Our aspirations still disappoint.
    Catheter Cardiovasc Interv. 2016;87:661-2.
    PubMed     Text format     Abstract available


  162. BLANKENSHIP JC
    When in doubt, aspirate.
    Catheter Cardiovasc Interv. 2016;87:648-9.
    PubMed     Text format     Abstract available


  163. CHEN X, Zhang D, Yin D, Li J, et al
    Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:554-63.
    PubMed     Text format     Abstract available


  164. XU B, Qian J, Ge J, Wang J, et al
    Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:624-9.
    PubMed     Text format     Abstract available


  165. TANAKA Y, Saito S
    Successful retrieval of a firmly stuck rotablator burr by using a modified STAR technique.
    Catheter Cardiovasc Interv. 2016;87:749-56.
    PubMed     Text format     Abstract available


  166. SECCO GG, Serdoz R, Kilic ID, Caiazzo G, et al
    Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Catheter Cardiovasc Interv. 2016;87:712-9.
    PubMed     Text format     Abstract available


  167. DE WAHA S, Allali A, Buttner HJ, Toelg R, et al
    Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    Catheter Cardiovasc Interv. 2016;87:691-700.
    PubMed     Text format     Abstract available


  168. GIUSTINO G, Baber U, Mastoris I, Vlachojannis GJ, et al
    One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Catheter Cardiovasc Interv. 2016;87:703-9.
    PubMed     Text format     Abstract available


  169. AMANN U, Kirchberger I, Heier M, von Scheidt W, et al
    Acute myocardial infarction in the elderly: Treatment strategies and 28-day-case fatality from the MONICA/KORA myocardial infarction registry.
    Catheter Cardiovasc Interv. 2016;87:680-8.
    PubMed     Text format     Abstract available


  170. VO MN, Karmpaliotis D, Brilakis ES
    "Move the cap" technique for ambiguous or impenetrable proximal cap of coronary total occlusion.
    Catheter Cardiovasc Interv. 2016;87:742-8.
    PubMed     Text format     Abstract available


  171. KIM CY, Lee AC, Wiedenbeck TL, Lee MS, et al
    Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:671-7.
    PubMed     Text format     Abstract available


  172. BOE BA, Bocks ML, Armstrong AK
    Contained rupture of patched right ventricular outflow tracts during balloon sizing for percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2016;87:768-72.
    PubMed     Text format     Abstract available


  173. ELEID MF, Asirvatham SJ, Cabalka AK, Hagler DJ, et al
    Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads.
    Catheter Cardiovasc Interv. 2016;87:E160-5.
    PubMed     Text format     Abstract available


    February 2016
  174. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available


  175. WEBB JG, Dvir D
    Transcatheter valve implantation for calcific mitral valve disease.
    Catheter Cardiovasc Interv. 2016;87:549-50.
    PubMed     Text format     Abstract available


  176. BELARDI JA, Albertal M
    Acute kidney injury after TAVI: Predict, detect, and prevent.
    Catheter Cardiovasc Interv. 2016;87:532-3.
    PubMed     Text format     Abstract available


  177. HILLEGASS WB
    Risk-guided use of the direct thrombin inhibitor bivalirudin.
    Catheter Cardiovasc Interv. 2016;87:401-2.
    PubMed     Text format     Abstract available


  178. BADER Y, Kimmelstiel C
    Thrombin inhibition during PCI in heart failure patients.
    Catheter Cardiovasc Interv. 2016;87:374-5.
    PubMed     Text format     Abstract available


  179. PHILLIPS AB, Nevin P, Shah A, Olshove V, et al
    Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of fallot.
    Catheter Cardiovasc Interv. 2016;87:403-10.
    PubMed     Text format     Abstract available


  180. CARDOSO R, Ansari M, Garcia D, Sandhu S, et al
    Prestenting for prevention of melody valve stent fractures: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016;87:534-9.
    PubMed     Text format     Abstract available


  181. ABU HAZEEM A, Aldoss O, Fagan T
    A novel method to prevent recurrent balloon rupture during dilation of heavily calcified conduits in preparation for transcatheter pulmonary valve placement.
    Catheter Cardiovasc Interv. 2016;87:421-5.
    PubMed     Text format     Abstract available


  182. MULLER B, Ghawi H, Heitschmidt MG, Fogg L, et al
    Medium-term CT evaluation of stent geometry, integrity, and valve function of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.
    Catheter Cardiovasc Interv. 2016;87:E97-103.
    PubMed     Text format     Abstract available


  183. CASADONTE JR, Wax DF, Gossett JG
    Extracardiac Fontan fenestration using the SafeSept transseptal guidewire and snare-controlled diabolo-shaped covered-stent placement.
    Catheter Cardiovasc Interv. 2016;87:426-31.
    PubMed     Text format     Abstract available


  184. SMOLKA G, Pysz P, Jasinski M, Roleder T, et al
    Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: A prospective registry.
    Catheter Cardiovasc Interv. 2016;87:478-87.
    PubMed     Text format     Abstract available


  185. SUGIYAMA H, Ishii T, Nakanishi T
    Successful coil embolization for Fontan-rout to aorta communication-recovery from complication of Brockenbrough procedure in Fontan patient.
    Catheter Cardiovasc Interv. 2016;87:E83-5.
    PubMed     Text format     Abstract available


  186. LIAO YB, He ZX, Zhao ZG, Wei X, et al
    The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation-A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016 Feb 9. doi: 10.1002/ccd.26443.
    PubMed     Text format     Abstract available


  187. ECHEVERRIA A, Krajcer Z
    Vascular complications in steroid treated patients undergoing trans-femoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2016;87:347-8.
    PubMed     Text format     Abstract available


  188. KORNOWSKI R
    The alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016;87:339-40.
    PubMed     Text format     Abstract available


  189. SAFIAN RD
    Restenosis after PCI: Battered but not beaten.
    Catheter Cardiovasc Interv. 2016;87:209-10.
    PubMed     Text format    


  190. GEIR SOLBERG O, Aaberge L, Ragnarsson A, Aas M, et al
    Comparison of simplified and comprehensive methods for assessing the index of microvascular resistance in heart transplant recipients.
    Catheter Cardiovasc Interv. 2016;87:283-90.
    PubMed     Text format     Abstract available


    January 2016
  191. TOKAREK T, Siudak Z, Dziewierz A, Sobczynski R, et al
    Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Jan 23. doi: 10.1002/ccd.26400.
    PubMed     Text format     Abstract available


  192. CERILLO AG, Griese D, Berti S
    Successful percutaneous implantation of symetis ACURATE neo transcatheter aortic bioprosthesis for the treatment of pure aortic regurgitation.
    Catheter Cardiovasc Interv. 2016 Jan 13. doi: 10.1002/ccd.26402.
    PubMed     Text format     Abstract available


  193. ABRAMOWITZ Y, Chakravarty T, Jilaihawi H, Cox J, et al
    Impact of body mass index on the outcomes following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26394.
    PubMed     Text format     Abstract available


  194. HILLEGASS WB
    Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
    Catheter Cardiovasc Interv. 2016;87:63-4.
    PubMed     Text format     Abstract available


  195. TOMMASO CL
    Learning curves for TAVR: Not quite see one, do one teach one.
    Catheter Cardiovasc Interv. 2016;87:163-4.
    PubMed     Text format     Abstract available


  196. CILINGIROGLU M, Marmagkiolis K
    A glimpse into the future of TAVR.
    Catheter Cardiovasc Interv. 2016;87:152-3.
    PubMed     Text format     Abstract available


  197. CHANDRASEKHAR J, Mehran R
    Same or next day discharge: A new chapter in transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016;87:143-4.
    PubMed     Text format     Abstract available


  198. BANG VV, Levy MS
    In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
    Catheter Cardiovasc Interv. 2016;87:13-4.
    PubMed     Text format     Abstract available


  199. HOLZER RJ, Hijazi ZM
    Transcatheter pulmonary valve replacement: State of the art.
    Catheter Cardiovasc Interv. 2016;87:117-28.
    PubMed     Text format     Abstract available


  200. HERMUZI A, McBrien A, De Rita F, McCheyne A, et al
    Hybrid transatrial stent insertion for left atrial decompression in hypoplastic left heart syndrome with intact atrial septum.
    Catheter Cardiovasc Interv. 2016;87:109-16.
    PubMed     Text format     Abstract available


  201. KITANO M, Yazaki S, Kagisaki K
    Ductal stenting using side-branch cell dilation for aortic coarctation in high-risk patients with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;87:E23-9.
    PubMed     Text format     Abstract available


  202. CRUZ-GONZALEZ I, Palazuelos Molinero J, Valenzuela M, Rada I, et al
    Brain natriuretic peptide levels variation after left atrial appendage occlusion.
    Catheter Cardiovasc Interv. 2016;87:E39-43.
    PubMed     Text format     Abstract available


  203. KATOH H, Nozue T, Michishita I
    A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention.
    Catheter Cardiovasc Interv. 2016;87:83-9.
    PubMed     Text format     Abstract available


  204. NOAD RL, Johnston N, McKinley A, Dougherty M, et al
    A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.
    Catheter Cardiovasc Interv. 2016;87:134-42.
    PubMed     Text format     Abstract available


  205. ZIMARINO M, Ricci F, Romanello M, Di Nicola M, et al
    Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Catheter Cardiovasc Interv. 2016;87:3-12.
    PubMed     Text format     Abstract available


  206. ROSS MM, Schamberger MS, Hoyer MH
    Resolution of inferior venous baffle leak and total venous occlusion using a bare stent and the gore((R)) excluder( (R)) aortic extension in transposition of the great arteries after mustard procedure.
    Catheter Cardiovasc Interv. 2016;87:E19-22.
    PubMed     Text format     Abstract available


    December 2015
  207. KOIFMAN E, Kiramijyan S, Negi SI, Didier R, et al
    Body mass index association with survival in severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Dec 30. doi: 10.1002/ccd.26377.
    PubMed     Text format     Abstract available


  208. THAKKAR B, Patel A, Mohamad B, Patel NJ, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26345.
    PubMed     Text format     Abstract available


  209. FELDMAN T, Reardon MJ
    Mitral valve-in-valve with the lotus mechanically expanding platform.
    Catheter Cardiovasc Interv. 2015;86:1287-1288.
    PubMed     Text format     Abstract available


    November 2015
  210. MONT'ALVERNE-FILHO JR, Rodrigues-Sobrinho CR, Medeiros F, Falcao FC, et al
    Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study.
    Catheter Cardiovasc Interv. 2015 Nov 28. doi: 10.1002/ccd.26334.
    PubMed     Text format     Abstract available


  211. PURI R, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, et al
    Transcatheter mitral valve implantation for inoperable severely calcified native mitral valve disease: A systematic review.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26262.
    PubMed     Text format     Abstract available


  212. ABRAMOWITZ Y, Jilaihawi H, Chakravarty T, Kashif M, et al
    Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26311.
    PubMed     Text format     Abstract available


  213. HALKIN A, Steinvil A, Aviram G, Biner S, et al
    Aortic regurgitation following transcatheter aortic valve replacement: Impact of preprocedural left ventricular diastolic filling patterns on late clinical outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26298.
    PubMed     Text format     Abstract available


  214. BELARDI JA, Albertal M
    Transcatheter aortic valve implantation: Watch out for the leak, irrespective of aortic valve disease type.
    Catheter Cardiovasc Interv. 2015;86:886-7.
    PubMed     Text format     Abstract available


  215. LUCAS V
    "I see the light!" trans-carotid balloon valvuloplasty in neonates and small infants utilizing continuous trans-esophageal echo guidance.
    Catheter Cardiovasc Interv. 2015;86:828.
    PubMed     Text format     Abstract available


    October 2015
  216. KRISHNASWAMY A, Latib A, Malik A, Bertoldi L, et al
    Resource utilization for transfemoral transcatheter aortic valve replacement: An international comparison.
    Catheter Cardiovasc Interv. 2015 Oct 28. doi: 10.1002/ccd.26056.
    PubMed     Text format     Abstract available


  217. REINOHL J, Psyrakis D, Kaier K, Kodirov S, et al
    Aortic root volume is associated with contained rupture of the aortic annulus in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Oct 26. doi: 10.1002/ccd.26260.
    PubMed     Text format     Abstract available


  218. BAPAT V, Pirone F, Kapetanakis S, Rajani R, et al
    Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1.
    Catheter Cardiovasc Interv. 2015;86:747-760.
    PubMed     Text format     Abstract available


  219. JATENE T, Bhatt DL
    TAVR in patients with severe aortic stenosis and less than high risk: Future or present reality?
    Catheter Cardiovasc Interv. 2015;86:745-746.
    PubMed     Text format     Abstract available


  220. DEBRY N, Sudre A, Amr G, Delhaye C, et al
    Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26253.
    PubMed     Text format     Abstract available


  221. MINHA S, Waksman R, Satler LP, Torguson R, et al
    Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Success and safety.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26121.
    PubMed     Text format     Abstract available


  222. CABASA AS, Eleid MF, Suri RM
    Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26264.
    PubMed     Text format     Abstract available


    September 2015
  223. LEDERMAN RJ, Babaliaros VC, Greenbaum AB
    How to perform transcaval access and closure for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26141.
    PubMed     Text format     Abstract available


  224. SINGH RAO R, Shapiro RL, Lasala JM
    No reflow leading to catastrophic hemodynamic collapse in a patient with severe aortic stenosis and its management.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26233.
    PubMed     Text format     Abstract available


  225. SALEH N, De Palma R, Settergren M, Ruck A, et al
    Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.25966.
    PubMed     Text format     Abstract available


  226. KHEIWA A, Turner D, Schreiber T
    Left main coronary artery embolization in an 11-year-old girl due to inflammatory myofibroblastic tumor of the mitral valve.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.26149.
    PubMed     Text format     Abstract available


    August 2015
  227. TRUONG UT, Fagan TE, Deterding R, Ing RJ, et al
    Use of rotational angiography in assessing relationship of the airway to vasculature during cardiac catheterization.
    Catheter Cardiovasc Interv. 2015 Aug 17. doi: 10.1002/ccd.26004.
    PubMed     Text format     Abstract available


  228. KOIFMAN E, Segev A, Fefer P, Barbash I, et al
    Comparison of acute kidney injury classifications in patients undergoing transcatheter aortic valve implantation: Predictors and long-term outcomes.
    Catheter Cardiovasc Interv. 2015 Aug 13. doi: 10.1002/ccd.26138.
    PubMed     Text format     Abstract available


  229. TRIANTAFYLLIS AS, Kortlandt F, Bakker AL, Swaans MJ, et al
    Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2015 Aug 13. doi: 10.1002/ccd.26137.
    PubMed     Text format     Abstract available


  230. BASIR MB, Velez C, Fuller B, Wyman J, et al
    Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation.
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.26116.
    PubMed     Text format     Abstract available


  231. ESCARCEGA RO, Magalhaes MA, Baker NC, Lipinski MJ, et al
    Does the disparity in baseline characteristics of patients undergoing transcatheter aortic valve replacement with 23 mm vs. 26 mm valves impact clinical outcome?
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.25967.
    PubMed     Text format     Abstract available


  232. ALLI O, Rihal CS, Suri RM, Greason KL, et al
    Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance.
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.26120.
    PubMed     Text format     Abstract available


    July 2015
  233. GENEREUX P, Demers P, Poulin F
    Same day discharge after transcatheter aortic valve replacement: Are we there yet?
    Catheter Cardiovasc Interv. 2015 Jul 21. doi: 10.1002/ccd.26059.
    PubMed     Text format     Abstract available


  234. SHIVARAJU A, Ott I, Cassese S, Bourier F, et al
    Fluoroscopic calcification-guided optimal deployment projection during transcatheter aortic valve replacement-"The eye of the pigtail."(Follow the right cusp rule-Part II).
    Catheter Cardiovasc Interv. 2015 Jul 14. doi: 10.1002/ccd.25929.
    PubMed     Text format    


    June 2015
  235. COCKBURN J, Singh MS, Rafi NH, Dooley M, et al
    Poor mobility predicts adverse outcome better than other frailty indices in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.25991.
    PubMed     Text format     Abstract available


  236. SAJI M, Rossi AM, Ailawadi G, Dent J, et al
    Adjunctive intracardiac echocardiography imaging from the left ventricle to guide percutaneous mitral valve repair with the mitraclip in patients with failed prior surgical rings.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.25981.
    PubMed     Text format     Abstract available


  237. WOHRLE J, Rodewald C, Rottbauer W
    Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.26062.
    PubMed     Text format     Abstract available


    May 2015
  238. CHIEFFO A, Van Mieghem NM, Tchetche D, Dumonteil N, et al
    Impact of mixed aortic valve stenosis on VARC-2 outcomes and postprocedural aortic regurgitation in patients undergoing transcatheter aortic valve implantation: Results from the international multicentric study PRAGMATIC (pooled Rotterdam-Milan-Toulou
    Catheter Cardiovasc Interv. 2015 May 29. doi: 10.1002/ccd.25975.
    PubMed     Text format     Abstract available


  239. SEDAGHAT A, Al-Rashid F, Sinning JM, Wendt D, et al
    Outcome in TAVI patients with symptomatic aortic stenosis not fulfilling PARTNER study inclusion criteria.
    Catheter Cardiovasc Interv. 2015 May 29. doi: 10.1002/ccd.25950.
    PubMed     Text format     Abstract available


  240. KISCHE S, D'Ancona G, Agma HU, Gurer H, et al
    Transcatheter, inflatable, and fully repositionable aortic valve: Preliminary results using a modified implantation technique.
    Catheter Cardiovasc Interv. 2015 May 27. doi: 10.1002/ccd.26039.
    PubMed     Text format     Abstract available


  241. FINK N, Segev A, Barbash I, Bogdan A, et al
    Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 May 23. doi: 10.1002/ccd.26014.
    PubMed     Text format     Abstract available


  242. BITTL JA, Tamis-Holland JE, Lang CD, He Y, et al
    Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: A Bayesian cross-design meta-analysis.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26025.
    PubMed     Text format     Abstract available


  243. DAUTOV R, Abdul Jawad Altisent O, Rinfret S
    Stumpless chronic total occlusion with no retrograde option: Multidetector Computed Tomography-Guided Intervention via Bi-Radial Approach Utilizing Bioresorbable Vascular Scaffold.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.25938.
    PubMed     Text format     Abstract available


  244. CONDADO J, Leonardi R, Babaliaros V
    Percutaneous tricuspid valve-In-ring replacement for the treatment of recurrent severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.25980.
    PubMed     Text format     Abstract available


  245. CIUCA C, Tarantini G, Latib A, Gasparetto V, et al
    Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26012.
    PubMed     Text format     Abstract available


  246. COLLAS VM, Dubois C, Legrand V, Kefer J, et al
    Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry.
    Catheter Cardiovasc Interv. 2015 May 11. doi: 10.1002/ccd.25999.
    PubMed     Text format     Abstract available


  247. WATANABE Y, Lefevre T, Bouvier E, Arai T, et al
    Prognostic value of aortic root calcification volume on clinical outcomes after transcatheter balloon-expandable aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 May 6. doi: 10.1002/ccd.25986.
    PubMed     Text format     Abstract available


    April 2015
  248. PHILIP F, Faza NN, Schoenhagen P, Desai MY, et al
    Aortic annulus and root characteristics in severe aortic stenosis due to bicuspid aortic valve and tricuspid aortic valves: Implications for transcatheter aortic valve therapies.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25948.
    PubMed     Text format     Abstract available


  249. LIM W, Smith T, Rogers JH
    Transcatheter repair of aortic leaflet perforation in a patient with prior surgical bicuspid aortic valve repair.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25958.
    PubMed     Text format     Abstract available


    March 2015
  250. ASHIKAGA T, Yoshikawa S, Isobe M
    The effectiveness of excimer laser coronary atherectomy with contrast medium for under-expanded stent; The findings of optical frequency domain imaging.
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25915.
    PubMed     Text format     Abstract available


    January 2015
  251. GARGIULO G, Sannino A, Capodanno D, Perrino C, et al
    Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients.
    Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25867.
    PubMed     Text format     Abstract available


  252. JILAIHAWI H, Wu Y, Yang Y, Xu L, et al
    Morphological characteristics of severe aortic stenosis in China: Imaging corelab observations from the first Chinese transcatheter aortic valve trial.
    Catheter Cardiovasc Interv. 2015 Jan 29. doi: 10.1002/ccd.25863.
    PubMed     Text format     Abstract available


  253. BUGAN B, Kapadia S, Svensson L, Krishnaswamy A, et al
    Novel hemodynamic index for assessment of aortic regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Jan 22. doi: 10.1002/ccd.25848.
    PubMed     Text format     Abstract available


  254. BIASCO L, De Backer O, Holme S, Sondergaard L, et al
    The "chimney approach" for transcatheter aortic valve implantation: a strategy for trans axillarian bareback approach in patients with no other access options.
    Catheter Cardiovasc Interv. 2015 Jan 19. doi: 10.1002/ccd.25840.
    PubMed     Text format     Abstract available


  255. BERNARDI FL, Gomes WF, de Brito FS, Mangione JA, et al
    Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry.
    Catheter Cardiovasc Interv. 2015 Jan 13. doi: 10.1002/ccd.25820.
    PubMed     Text format     Abstract available


  256. DVIR D, Webb JG, Piazza N, Blanke P, et al
    Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using either SAPIEN XT or CoreValve: Degree of Device Oversizing by Computed-Tomography and Clinical Outcomes.
    Catheter Cardiovasc Interv. 2015 Jan 9. doi: 10.1002/ccd.25823.
    PubMed     Text format     Abstract available


  257. MOUILLET G, Lellouche N, Yamamoto M, Oguri A, et al
    Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve devices: Results from the FRANCE 2 Registry.
    Catheter Cardiovasc Interv. 2015 Jan 8. doi: 10.1002/ccd.25818.
    PubMed     Text format     Abstract available


    December 2014
  258. ELLING R, Stiller B, Grohmann J
    Transcatheter device occlusion of the left ventricular outflow tract as treatment for severe aortic regurgitation in hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2014 Dec 22. doi: 10.1002/ccd.25782.
    PubMed     Text format     Abstract available


    November 2014
  259. GARG A, Parashar A, Agarwal S, Aksoy O, et al
    Comparison of acute elastic recoil between the SAPIEN-XT and SAPIEN valves in transfemoral-transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2014 Nov 4. doi: 10.1002/ccd.25717.
    PubMed     Text format     Abstract available


    October 2014
  260. BARBASH IM, Minha S, Ben-Dor I, Dvir D, et al
    Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Oct 17. doi: 10.1002/ccd.25708.
    PubMed     Text format     Abstract available


  261. SEIFFERT M, Conradi L, Terstesse AC, Koschyk D, et al
    Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Oct 8. doi: 10.1002/ccd.25691.
    PubMed     Text format     Abstract available


    September 2014
  262. SANBORN TA, Tomey MI, Mehran R, Genereux P, et al
    Femoral vascular closure device use, bivalirudin anticoagulation and bleeding after primary angioplasty for STEMI: Results from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2014 Sep 1. doi: 10.1002/ccd.25663.
    PubMed     Text format     Abstract available


    August 2014
  263. FREIXA X, Chan J, Bonan R, Ibrahim R, et al
    Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Aug 12. doi: 10.1002/ccd.25632.
    PubMed     Text format     Abstract available


    July 2014
  264. GUERCHICOFF A, Stone GW, Mehran R, Xu K, et al
    Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute st-segment elevation myocardial infarction: Results of the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2014 Jul 30. doi: 10.1002/ccd.25620.
    PubMed     Text format     Abstract available


  265. DE BACKER O, Lonn L, Sondergaard L
    Combined surgical and catheter-based treatment of extensive thoracic aortic aneurysm and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2014 Jul 2. doi: 10.1002/ccd.25592.
    PubMed     Text format     Abstract available


    June 2014
  266. SCHNABEL RB, Seiffert M, Wilde S, Schirmer J, et al
    Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort.
    Catheter Cardiovasc Interv. 2014 Jun 27. doi: 10.1002/ccd.25588.
    PubMed     Text format     Abstract available


    March 2014
  267. ABRAMOWITZ Y, Banai S, Katz G, Steinvil A, et al
    Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease.
    Catheter Cardiovasc Interv. 2014;83:649-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: